Sexual dysfunction with major depressive disorder and antidepressant treatments: impact, assessment, and management
- PMID: 35255754
- DOI: 10.1080/14740338.2022.2049753
Sexual dysfunction with major depressive disorder and antidepressant treatments: impact, assessment, and management
Abstract
Introduction: Sexual dysfunction (SD) is a symptom of depression in ≈70% of patients presenting with major depressive disorder (MDD). Antidepressant medications (AD) and adjunctive treatments may further contribute to SD and complicate evaluation and management.
Areas covered: A systematic literature search of PubMed, Ovid MEDLINE and Cochrane databases for MDD, SD, classes of antidepressants, etc. was performed with a focus on 2014 to June 2021. SSRIs are associated with 70% treatment-emergent sexual dysfunction (TESD), SNRIs and tricyclics have rates of TESD of 40-45%, and antidepressant medications without SRI effects or with additional unique mechanisms of action have rates similar to placebo (<10%). Appropriate assessment at baseline and throughout treatment, consideration of patient preferences in prescribing, addressing modifiable factors (comorbid medical/psychiatric conditions, substances, relationship difficulties), and utilizing management strategies of switching to an AD with less SD, adding an antidote/adjunctive therapy or lowering the dose are discussed.
Expert opinion: MDD and antidepressant treatment contribute to SD in a high percentage of patients. Treating to remission reduces SD as a symptom of depression. Frequent assessment and _targeted management strategies may be effective in preventing or addressing SD. Secondary outcomes like impact on adherence, relationships and self-image should also be considered.
Keywords: MDD; Major depressive disorder; SNRIs; SSRIs; TESD; antidepressants; sexual dysfunction; treatment-emergent sexual dysfunction.
Similar articles
-
Treatment-emergent sexual dysfunction in randomized trials of vortioxetine for major depressive disorder or generalized anxiety disorder: a pooled analysis.CNS Spectr. 2016 Oct;21(5):367-378. doi: 10.1017/S1092852915000553. Epub 2015 Nov 17. CNS Spectr. 2016. PMID: 26575433
-
Summary of findings from the FDA regulatory science forum on measuring sexual dysfunction in depression trials.J Clin Psychiatry. 2015 Aug;76(8):1050-9. doi: 10.4088/JCP.14r09699. J Clin Psychiatry. 2015. PMID: 26335083 Review.
-
Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.Aust N Z J Psychiatry. 2014 Jul;48(7):663-71. doi: 10.1177/0004867414525837. Epub 2014 Mar 6. Aust N Z J Psychiatry. 2014. PMID: 24604920
-
Sexual dysfunction associated with major depressive disorder and antidepressant treatment.Expert Opin Drug Saf. 2014 Oct;13(10):1361-74. doi: 10.1517/14740338.2014.951324. Epub 2014 Aug 22. Expert Opin Drug Saf. 2014. PMID: 25148932 Review.
-
Effect of Vortioxetine vs. Escitalopram on Sexual Functioning in Adults with Well-Treated Major Depressive Disorder Experiencing SSRI-Induced Sexual Dysfunction.J Sex Med. 2015 Oct;12(10):2036-48. doi: 10.1111/jsm.12980. Epub 2015 Aug 31. J Sex Med. 2015. PMID: 26331383 Clinical Trial.
Cited by
-
Intranasal Monophosphoryl Lipid a Administration Ameliorates depression-like Behavior in Chronically Stressed Mice Through Stimulation of Microglia.Neurochem Res. 2023 Oct;48(10):3160-3176. doi: 10.1007/s11064-023-03974-0. Epub 2023 Jun 26. Neurochem Res. 2023. PMID: 37358676
-
Influence of CYP2C19, CYP2D6, and ABCB1 Gene Variants and Serum Levels of Escitalopram and Aripiprazole on Treatment-Emergent Sexual Dysfunction: A Canadian Biomarker Integration Network in Depression 1 (CAN-BIND 1) Study.Can J Psychiatry. 2024 Mar;69(3):183-195. doi: 10.1177/07067437231203433. Epub 2023 Oct 5. Can J Psychiatry. 2024. PMID: 37796764 Free PMC article.
-
An interdisciplinary intervention for detection of sexual dysfunction associated with antidepressants: A pilot study.Ment Health Clin. 2024 Aug 2;14(4):236-241. doi: 10.9740/mhc.2024.08.236. eCollection 2024 Aug. Ment Health Clin. 2024. PMID: 39104433 Free PMC article.
-
The association of hypogonadism with depression and its treatments.Front Endocrinol (Lausanne). 2023 Aug 10;14:1198437. doi: 10.3389/fendo.2023.1198437. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37635965 Free PMC article. Review.
-
Prevalence of sexual dysfunction and its association with psychological symptoms in drug-naive major depressive disorder patients in West China.Front Psychiatry. 2023 Dec 7;14:1291988. doi: 10.3389/fpsyt.2023.1291988. eCollection 2023. Front Psychiatry. 2023. PMID: 38130293 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical